Jump to content
Clinical research in Brazil: understanding bill of law’s main points
Bill of Law No. 7.082/17 approved by the Brazilian House of Representatives addresses requirements for conducting research with human beings in Brazil.
Mockup of tablets reflecting the e-book's internal content
The growing number of scientific studies on the therapeutic properties of Cannabis Sativa and psychedelic substances points to the need for relevant updates in Brazilian regulation. Our Life Sciences and Health experts bring the most current...
Mockup ilustrativo de dois tablets, um acima do outro, com imagens do conteúdo interno do e-book. No canto superior direito, faixa descritiva nas cores amarelo e cinza, com o nome "e-book" escrito
Our eBook on the “Brazilian Regulatory Framework for Rare Diseases” is an essential guide to Brazil’s healthcare system, providing a comprehensive analysis of the regulatory processes related to rare disease medications, including gene and...
Illustrative mockup of two tablets, one above the other, with images of the e-book's internal content. In the top right-hand corner, a descriptive strip in yellow and gray, with the name "e-book" written on it.
Businesses have up to 180 days to comply with the new rules. To understand what changes, download our exclusive publication on the topic and stay updated with the latest guidelines in the healthcare sector.
Doctor wearing a white coat and holding a stethoscope while evaluating information on a notebook
Anvisa updates regulation on medical devices and opens public consultation on the use of analyzes performed by AREE.
Tablet on top of a leaflet
Anvisa approves regulation that allows the remote delivery of controlled drugs, including through public health programs.
Medicine shelf in a pharmacy
Anvisa RDC 811/23 reduces to 45 days the deadline to analyze whether requests for drugs registration should be classified as priorities.
Mockup of tablets reflecting the e-book's internal content
On September 26, 2023, the Ministry of Health (“MoH”) announced the new strategy for strengthening the health economic industrial complex, applicable to medicines, APIs, vaccines, diagnostic reagents, treatments and health services (“New CEIS Policy”). The Brazilian government estimates R$42.1 billion in investments (new Growth Acceleration Program - “PAC” for the CEIS, via public and private funding).
TCU recommends the ministry of health to suspend new PDPs
TCU recommends the Ministry of Health suspend new PDPs and gives a deadline for the agency to establish a schedule for calculating the value of tech transfers
Person typing on a laptop and holding a pen in one hand
medical advertising rules, Federal Council of Medicine, ethical rules for publicity and medical advertising, defines medical advertising, use of patients’ images, Commission for the Disclosure of Medical Affairs
Logo Machado Meyer

Ⓒ MACHADO, MEYER, SENDACZ AND OPICE ADVOGADOS 2023
ALL RIGHTS RESERVED